glp-1 mechanism of action Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. receptor agonists and GLP-1 and glucose-dependent insulinotropic What is GLP-1 and Its
Description
Atkin, P
aleniglipron and orforglipron) are functionally Gs-biased and recruit -arrestin poorly (which is typically involved in turning off the GLP-1 receptor's signal by promoting internalization and downregulation and mediating nausea and vomiting)
Diabetologia 53: 22332240
While effective during treatment, their long-term benefit hinges on whether weight loss persists after discontinuation
These brand names are referenced for nominative identification only and do not imply affiliation with or endorsement by those companies
91 SammsRJChristeMECollinsKALPirroVDrozBAHollandAKet al
